Retatrutide – 50 MG

Retatrutide – 50MG is a high-strength research peptide representing the next frontier in metabolic and obesity science. As a triple hormone receptor agonist—stimulating GLP-1, GIP, and glucagon receptors—Retatrutide is being actively investigated for its profound effects on weight reduction, glucose regulation, and fat metabolism.

This 50MG format is ideal for long-term studies or multi-subject research, offering unmatched value and convenience for professional laboratories and advanced research institutions.

Key Research Insights:

• Unprecedented Weight Loss: In clinical trials, Retatrutide achieved over 24% body weight reduction, outperforming Semaglutide and Tirzepatide.

• Triple Pathway Activation: Simultaneously targets insulin release, satiety signals, and lipid oxidation mechanisms.

• Metabolic Optimisation: Improves glycaemic control, reduces liver fat, and enhances mitochondrial energy utilisation.

• Potent Appetite Suppression: Acts both centrally and peripherally to reduce caloric intake.

Why Choose 50MG Retatrutide?

• Longer Protocols, Fewer Reorders: Ideal for full 4–12 week cycles.

• Premium Grade: >99% purity, HPLC-tested and verified.

• Backed by Science: Data from Eli Lilly trials supports its superior safety and efficacy profile in weight and metabolic regulation.

• Trusted Research Format: Lyophilised for stability, with extended shelf life pre-reconstitution.

Reconstitution Guidelines (Research Use Only):

• Reconstitute with 2–5ml of Bacteriostatic Water for Injection (BWFI)

• Store reconstituted vial at 2–8°C (refrigerated)

• Use within 30 days after reconstitution

⚠️ DISCLAIMER: Retatrutide is sold for scientific, research, and laboratory use only. It is not intended for human consumption or therapeutic use.